Prosecution Insights
Last updated: October 14, 2026

The Ohio State University

Technology area: Biotechnology & Pharmaceuticals

93 pending office actions • 71 art units • 90 examiners • 0 of 93 (0%) have an AI response strategy ready • 74 patents granted in the last 365 days

Analysis

The Ohio State University has 98 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 98 pending office actions are spread across 64 distinct art units, reflecting a broad range of scientific research and technical specialization within the university's patent filings. The prosecution involves 95 distinct examiners, which means almost every case is being handled by a different individual.

LAUER, CHRISTINA C is the busiest examiner for the university with 2 pending office actions. This low level of examiner concentration, with 95 distinct examiners for 98 pending office actions, highlights the decentralized nature of the university's prosecution efforts. Navigating 64 distinct art units in the Biotechnology & Pharmaceuticals sector requires the university to manage a wide variety of departmental standards and many individual examiner perspectives simultaneously. Practitioners must coordinate across 64 distinct art units and 95 distinct examiners to manage the 98 pending office actions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

93
Total Pending OAs
66
Non-Final OAs
24
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 35 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

21
Overdue
0
Due this week
11
Due this month
0
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 35 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (21)Due ≤ 30 days (11)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

54
Hard (58%)
34
Medium (37%)
3
Easy (3%)
2
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 + other14 (15%)
§103 only26 (28%)
§102 only2 (2%)
§112 only3 (3%)
Double-patenting + other6 (6%)
Multi-statute (no §101)40 (43%)
No statute on record2 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

58
Life Sciences
62% of docket
2
Information Tech
2% of docket
1
Communications
1% of docket
10
Semiconductors
11% of docket
22
Mechanical / Eng
24% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

930 h
Manual time on pending OAs
186 h
Time saved (low, 20%)
326 h
Time saved (mid, 35%)
8.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LAUER, CHRISTINA C 2 68.6% +14.2%
GOURLIE, LAURA ELOISE 2 66.1% +37.2%
VALENROD, YEVGENY 2 72.5% +25.1%
BROCKMAN, ELDON T 1 85.0% +5.7%
KAZIMI, MAHMOUD M 1 65.3% +18.0%
DABKOWSKI, ERINNE R 1 55.8% +68.8%
LIEB, JEANETTE M 1 79.9% +17.2%
SHIRSAT, MARCELA 1 73.6% +19.0%
CARDIMINO, CHRISTOPHER RYAN 1 58.1% +22.8%
PREM, SAIPRATAP 1 — —

Hard Cases (54)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18739226 CLINICAL DECISION SUPPORT SYSTEM AND METHOD HIGGS, STELLA EUN 71d overdue
17442471 ENGINEERED MRNA SEQUENCES AND USES THEREOF PENNINGTON, KATIE LEIGH 51d overdue
18695459 INDUCED ELECTRIC FIELD (IEF) THERAPY FOR TREATMENT OF SOLID CANCERS D ABREU, MICHAEL JOSEPH 31d overdue
18695728 INNER POROUS SCREW TYPE IMPLANT EIDE, HEIDI MARIE 22d overdue
18975570 SYSTEMS AND METHODS FOR PREDICTIVE HEART VALVE SIMULATION TALTY, MARIA CHRISTINA 3d overdue
17775236 METHODS AND COMPOSITIONS RELATING TO SELECTIVE INTRACELLULAR DELIVERY OF CD38 INHIBITORS VIVLEMORE, TRACY ANN 3d overdue
18548719 Method of Evaluating the Biofilm Detachment Efficacy of Compositions SWIFT, CANDICE LEE 2d overdue
17608441 Reagents and Methods for Alzheimer's Disease and CoMorbidities Thereof PLAYER, ROBERT AUSTIN 1d overdue

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18293052 DEVICE AND METHOD FOR VIBRATION FREE LOW TEMPERATURE SAMPLE HOLDER FOR SIDE ENTRY ELECTRON MICROSCOPES GOURLIE, LAURA ELOISE 27d
18962504 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 28d
18688553 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 28d
19329417 CELL-PENETRATING PEPTIDE COMPOUNDS DABKOWSKI, ERINNE R 83d
19479898 SYSTEMS AND METHODS FOR EVALUATING PROCEDURES FOR ENVISIONED AIR MOBILITY OPERATIONS KAZIMI, MAHMOUD M —
19329431 INTRACELLULAR DELIVERY OF NUCLEIC ACIDS LIEB, JEANETTE M —
19275071 SYSTEMS AND METHODS FOR MECHANICAL DISPLACEMENT OF AN ESOPHAGUS SHIRSAT, MARCELA —
19207877 RANGE EXTENSION WITH OPTIMAL TRACTION CONTROL FOR MULTI E-AXLE BASED ELECTRIFIED VEHICLES CARDIMINO, CHRISTOPHER RYAN —

Top Art Units

Art UnitApps
1628 3
1638 3
1636 3
3799 2
1654 2
3661 2
3663 2
3771 2
2881 2
1633 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19484758 ACTIVE FLOW CONTROL ENABLED VARIABLE AREA TURBINE VANE BROCKMAN, ELDON T 3799 §102§112 Non-Final OA — Pending Nov 14, 2025
19479898 SYSTEMS AND METHODS FOR EVALUATING PROCEDURES FOR ENVISIONED AIR MOBILITY OPERATIONS KAZIMI, MAHMOUD M 3665 §101§102§103 Non-Final OA — Pending Oct 29, 2025
19329417 CELL-PENETRATING PEPTIDE COMPOUNDS DABKOWSKI, ERINNE R 1654 §103Other Final Rejection 83d Pending Sep 15, 2025
19329431 INTRACELLULAR DELIVERY OF NUCLEIC ACIDS LIEB, JEANETTE M 1654 §103§112DP Non-Final OA — Pending Sep 15, 2025
19275071 SYSTEMS AND METHODS FOR MECHANICAL DISPLACEMENT OF AN ESOPHAGUS SHIRSAT, MARCELA 3775 §102§103DP Non-Final OA — Pending Jul 21, 2025
19207877 RANGE EXTENSION WITH OPTIMAL TRACTION CONTROL FOR MULTI E-AXLE BASED ELECTRIFIED VEHICLES CARDIMINO, CHRISTOPHER RYAN 3661 §101§102§103 Non-Final OA — Pending May 14, 2025
19113726 SYSTEMS AND METHODS FOR MODELING VULNERABILITY AND ATTACKABILITY PREM, SAIPRATAP 2494 §101§103 Non-Final OA — Pending Mar 20, 2025
19106073 SYSTEMS AND METHODS FOR COOPERATIVE NAVIGATION WITH AUTONOMOUS VEHICLES SMITH-STEWART, DEMETRA R 3661 §102§103 Non-Final OA — Pending Feb 24, 2025
19046648 MODULAR MULTILEVEL FLYING CAPACITOR CONVERTER LEE, JYE-JUNE 2838 §103§112 Non-Final OA — Pending Feb 06, 2025
19100237 SYSTEMS AND METHODS FOR HYBRID AUTONOMOUS MANUFACTURING AVERICK, LAWRENCE 3799 §103§112 Final Rejection — Pending Jan 31, 2025
18975570 SYSTEMS AND METHODS FOR PREDICTIVE HEART VALVE SIMULATION TALTY, MARIA CHRISTINA 3797 §102§103§112 Final Rejection 3d overdue Pending Dec 10, 2024
18870856 METHODS AND SYSTEMS FOR CONTROLLING VEHICLE POWERTRAINS LINHARDT, LAURA E 3663 §103 Non-Final OA 8d overdue Pending Dec 02, 2024
18962504 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 3771 §103§112 Non-Final OA 28d Pending Nov 27, 2024
18961890 METHOD FOR QUENCH DETECTION USING RF INTERROGATION OF COOLANT PERMITTIVITY LIU, KENDRICK X 2853 §103 Non-Final OA — Pending Nov 27, 2024
18950757 CLADDING MAGNET APPLICATION TO CYCLOIDAL MAGNETIC GEARS CHANG, MINKI 2834 §102§103 Non-Final OA — Pending Nov 18, 2024
18866675 SYSTEM AND METHOD FOR EARLY DETECTION OF COGNITIVE IMPAIRMENT USING COGNITIVE TEST RESULTS WITH ITS BEHAVIORAL METADATA LANE, DANIEL E 3715 §101§102§103§112 Non-Final OA — Pending Nov 18, 2024
18946152 METHOD AND APPARATUS OF CHANNEL ESTIMATION IN ULTRA-WIDEBAND COMMUNICATION TADESE, BERHANU 2632 §103 Non-Final OA — Pending Nov 13, 2024
18865208 AIR-TIGHT AMBIENT MASS SPECTROMETRY GOURLIE, LAURA ELOISE 2881 §103 Non-Final OA — Pending Nov 12, 2024
18934431 COUPLED AUTONOMOUS PODS FOR SHARED MOBILITY RAMESH, KRISHNAN 3663 §103 Final Rejection 20d Pending Nov 01, 2024
18848613 PHARMACEUTICAL COMBINATIONS AND METHODS OF USE OF AMINO-PYRROLOPYRIMIDINONE COMPOUND VALENROD, YEVGENY 1628 §103§112DP Non-Final OA — Pending Sep 19, 2024
18846152 ELECTROSPRAY EMITTER DEVICES AND METHODS OF USE THEREOF MASKELL, MICHAEL P 2878 §102§103 Non-Final OA — Pending Sep 11, 2024
18826539 ETCHING METHODS AND PATTERNED SUBSTRATES MADE USING SAID METHODS DEO, DUY VU NGUYEN 1713 §103§112 Non-Final OA — Pending Sep 06, 2024
18825158 APPARATUS AND METHOD FOR ENHANCED DETERMINATION OF OPTIMAL OPERATIONAL SEPARATION FOR COLLABORATIVE ROBOTIC SYSTEMS OH, HARRY Y 3657 — Non-Final OA — Pending Sep 05, 2024
18819397 X-RAY ASSISTIVE DEVICE FOR STANDARDIZING THE KNEE TEMPLATING BOOSALIS, FANI POLYZOS 2884 §103 Non-Final OA — Pending Aug 29, 2024
18838519 Cerebrovascular-Tumor-On-A-Chip WILSON, MICHAEL C 1638 §102§103§112 Non-Final OA — Pending Aug 14, 2024
18777701 DEVICE TO CREATE REPRODUCIBLE FENESTRATIONS IN A NON-VALVED TUBE SHUNT TENTONI, LEO B 1742 §102§103§112 Non-Final OA — Pending Jul 19, 2024
18730155 ALKANOLAMINE-CONTAINING MEMBRANES AND METHODS OF MAKING AND USING THEREOF LAWRENCE JR, FRANK M 1776 §102§103§112 Non-Final OA — Pending Jul 18, 2024
18726968 ELECTRO-SPINNING METHODS AND USES THEREOF MALEKZADEH, SEYED MASOUD 1754 §103§112 Non-Final OA — Pending Jul 05, 2024
18739226 CLINICAL DECISION SUPPORT SYSTEM AND METHOD HIGGS, STELLA EUN 3681 §101§103 Non-Final OA 71d overdue Pending Jun 10, 2024
18716634 COMPOSITIONS AND METHODS FOR PRODUCTION AND USE OF A SCALABLE HUMAN CELL-DERIVED EXTRACELLULAR MATRIX SPENCE, JENNIFER SUZANNE 1633 §103§112 Non-Final OA — Pending Jun 05, 2024
18716721 DIAMINO LIPID (DAL) COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING AN IMMUNOTHERAPEUTIC AGENT WRIGHT, SARAH C 1619 §103 Non-Final OA — Pending Jun 05, 2024
18714308 ENGINEERED CELLS AND USES THEREOF AMICK, THOMAS RUSSE 1638 §102§112 Non-Final OA — Pending May 29, 2024
18712524 COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS KONOPKA, CATHERINE ANNE 1611 §103§112 Non-Final OA — Pending May 22, 2024
18710916 COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES AND INJURIES VIGIL, TORIANA NICHOLE 1612 §102§103§112 Non-Final OA 14d Pending May 16, 2024
18564982 COMPOSITIONS FOR RNA-PROTEIN TETHERING AND METHODS OF USING STANKOVIC, BRATISLAV 1662 §103 Final Rejection 98d overdue Pending May 16, 2024
18646287 BLOOD VESSEL LOCATOR BUI PHO, PASCAL M 3798 §102§103§112 Non-Final OA — Pending Apr 25, 2024
18644750 CYCLIC CELL-PENETRATING PEPTIDES WITH ONE OR MORE HYDROPHOBIC RESIDUES COFFA, SERGIO 1658 §102 Non-Final OA 12d Pending Apr 24, 2024
18703637 IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER PURDY, KYLE A 1611 §103 Non-Final OA — Pending Apr 22, 2024
18703633 COMPOSITIONS AND METHODS OF THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS EVANS, JASMINE AFIYA 1616 §103§112 Non-Final OA — Pending Apr 22, 2024
18703008 ARYLIMIDAMIDES FOR USE IN TREATMENT OF CANCERS VALENROD, YEVGENY 1628 §102§112 Non-Final OA — Pending Apr 19, 2024
18635747 METHODS AND SYSTEMS FOR ALIGNING AN EYE FOR MAKING A DETERMINATION ABOUT THE EYE USING REMOTE OR TELEHEALTH PROCEDURES KAUFFMAN, RUBY LUCIA 2872 §103 Non-Final OA — Pending Apr 15, 2024
18695459 INDUCED ELECTRIC FIELD (IEF) THERAPY FOR TREATMENT OF SOLID CANCERS D ABREU, MICHAEL JOSEPH 3796 §102§103 Final Rejection 31d overdue Pending Mar 26, 2024
18695728 INNER POROUS SCREW TYPE IMPLANT EIDE, HEIDI MARIE 3772 §103§112 Non-Final OA 22d overdue Pending Mar 26, 2024
18688553 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 3771 §101§103§112 Non-Final OA 28d Pending Mar 01, 2024
18687974 COATINGS AND METHODS OF MAKING AND USE THEREOF KESSLER JR, THOMAS JOSEPH 1782 §102§103 Non-Final OA — Pending Feb 29, 2024
18687973 PLASTICIZED BIOPOLYMER COMPOSITIONS AND METHODS OF MAKING THEREOF EGWIM, KELECHI CHIDI 1762 §102§103 Non-Final OA — Pending Feb 29, 2024
18293052 DEVICE AND METHOD FOR VIBRATION FREE LOW TEMPERATURE SAMPLE HOLDER FOR SIDE ENTRY ELECTRON MICROSCOPES GOURLIE, LAURA ELOISE 2881 §102§103 Final Rejection 27d Pending Jan 29, 2024
18419130 SYSTEMS AND METHODS FOR MEASURING AND AUDITING FAIRNESS TANK, ANDREW L 2141 §101§102§103§112 Non-Final OA — Pending Jan 22, 2024
18579084 COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS RAMADAN, OMAR 1678 §101§102§112 Non-Final OA — Pending Jan 12, 2024
18396859 FLUORINATED LITHIUM-RICH AND MANGANESE-BASED OXIDE POSITIVE ELECTRODE MATERIALS FOR BATTERIES THAT CYCLE LITHIUM IONS AND METHODS OF MANUFACTURING THE SAME CHMIELECKI, SCOTT J 1729 §102§103 Non-Final OA — Pending Dec 27, 2023

View all 93 →

Managing The Ohio State University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does The Ohio State University have?

The Ohio State University has 93 pending office actions as of October 2026, spread across 71 art units and 90 examiners.

Which USPTO examiner handles the most The Ohio State University applications?

Christina C Lauer has the most, with 2 of The Ohio State University's pending office actions.

What technology area are The Ohio State University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month